LONDON: GlaxoSmithKline is cutting the price charged for its pneumococcal vaccine when given to refugees, following complaints about the product's "exorbitant" cost by medical charity Medecins Sans Frontieres.
LONDON: GlaxoSmithKline and Google parent Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics.
SHANGAI/LONDON: China fined GlaxoSmithKline Plc a record 3 billion yuan ($489 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drugmaker.
LONDON: Could Pfizer acquire GlaxoSmithKline as a "plan B" after failing to land AstraZeneca? It would be a stretch but not totally impossible, according to analysts at Berenberg Bank.